Ετικέτες

Τρίτη 30 Μαΐου 2017

Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction.

Author: Messerli, Franz H. MD; Bangalore, Sripal MD, MHA
Page: 2085-2087


http://ift.tt/2rmeIGM

Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox.

Author: Strauss, Martin H. MD, BSc; Hall, Alistair S. MB ChB, PhD
Page: 2088-2090


http://ift.tt/2skkkP8

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.

Author: Natarajan, Pradeep MD, MMSc *; Young, Robin PhD *; Stitziel, Nathan O. MD, PhD; Padmanabhan, Sandosh MD, PhD; Baber, Usman MD; Mehran, Roxana MD; Sartori, Samantha PhD; Fuster, Valentin MD, PhD; Reilly, Dermot F. PhD; Butterworth, Adam PhD; Rader, Daniel J. MD; Ford, Ian PhD +; Sattar, Naveed MD, PhD +; Kathiresan, Sekar MD +
Page: 2091-2101


http://ift.tt/2rm8s25

Common Variants for Cardiovascular Disease: Clinical Utility Confirmed.

Author: Humphries, Steve E. PhD
Page: 2102-2105


http://ift.tt/2sknC4U

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.

Author: Halliday, Brian P. MBChB; Gulati, Ankur MD; Ali, Aamir MBChB; Guha, Kaushik MD; Newsome, Simon MSc; Arzanauskaite, Monika MD; Vassiliou, Vassilios S. MBBS; Lota, Amrit BMBCh; Izgi, Cemil MD; Tayal, Upasana BMBCh; Khalique, Zohya MBBS; Stirrat, Colin MBChB; Auger, Dominique MD; Pareek, Nilesh MD; Ismail, Tevfik F. PhD; Rosen, Stuart D. MD; Vazir, Ali PhD; Alpendurada, Francisco PhD; Gregson, John PhD; Frenneaux, Michael P. PhD; Cowie, Martin R. MD; Cleland, John G. F. PhD; Cook, Stuart A. PhD; Pennell, Dudley J. MD; Prasad, Sanjay K. MD
Page: 2106-2115


http://ift.tt/2rmoaKl

Risk Stratification for Sudden Cardiac Death: Is It Too Late to Establish a Role for Cardiac MRI?.

Author: Markman, Timothy M. MD; Nazarian, Saman MD, PhD
Page: 2116-2118


http://ift.tt/2skn1Ak

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

Author: de Lemos, James A. MD; Ayers, Colby R. MS; Levine, Benjamin MD; deFilippi, Christopher R. MD; Wang, Thomas J. MD; Hundley, W. Gregory MD; Berry, Jarett D. MD, MS; Seliger, Stephen L. MD; McGuire, Darren K. MD, MHSc; Ouyang, Pamela MBBS; Drazner, Mark H. MD, MSc; Budoff, Matthew MD; Greenland, Philip MD; Ballantyne, Christie M. MD; Khera, Amit MD, MSc
Page: 2119-2132


http://ift.tt/2rlZ3r9

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Author: Perez de Isla, Leopoldo MD, PhD; Alonso, Rodrigo MD, PhD; Mata, Nelva MD, PhD; Fernandez-Perez, Cristina MD, PhD; Muniz, Ovidio MD, PhD; Diaz-Diaz, Jose Luis MD, PhD; Saltijeral, Adriana MD, PhD; Fuentes-Jimenez, Francisco MD, PhD; de Andres, Raimundo MD, PhD; Zambon, Daniel MD, PhD; Piedecausa, Mar MD; Cepeda, Jose Maria MD; Mauri, Marta MD; Galiana, Jesus MD, PhD; Brea, Angel MD, PhD; Sanchez Munoz-Torrero, Juan Francisco MD, PhD; Padro, Teresa PhD; Argueso, Rosa MD; Miramontes-Gonzalez, Jose Pablo MD, PhD; Badimon, Lina PhD; Santos, Raul D. MD, PhD; Watts, Gerald F. MD, DSc; Mata, Pedro MD, PhD
Page: 2133-2144


http://ift.tt/2sk7YGX

Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials.

Author: Montone, Rocco A. MD; Niccoli, Giampaolo MD, PhD; De Marco, Federico MD, PhD; Minelli, Silvia MD; D'Ascenzo, Fabrizio MD; Testa, Luca MD, PhD; Bedogni, Francesco MD; Crea, Filippo MD, PhD
Page: 2145-2154


http://ift.tt/2rmgYxI

[gamma][delta] T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.

Author: Caillon, Antoine PhD; Mian, Muhammad Oneeb Rehman PhD; Fraulob-Aquino, Julio C. PhD; Huo, Ku-Geng BSc; Barhoumi, Tlili PhD; Ouerd, Sofiane MSc; Sinnaeve, Peter R. MD, PhD; Paradis, Pierre PhD; Schiffrin, Ernesto L. MD, PhD
Page: 2155-2162


http://ift.tt/2skdRno

Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.

Author: Sag, Can Martin MD *; Schnelle, Moritz MD, PhD *; Zhang, Juqian MD; Murdoch, Colin E. PhD; Kossmann, Sabine PhD; Protti, Andrea PhD; Santos, Celio X.C. PhD; Sawyer, Greta PhD; Zhang, Xiaohong MD; Mongue-Din, Heloise PhD; Richards, Daniel A. PhD; Brewer, Alison C. PhD; Prysyazhna, Oleksandra PhD; Maier, Lars S. MD; Wenzel, Philip MD; Eaton, Philip J. PhD; Shah, Ajay M. MD
Page: 2163-2177


http://ift.tt/2rmf7JF

Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular-Driven Disease?.

Author: de Roos, Albert MD; van der Grond, Jeroen PhD; Mitchell, Gary MD; Westenberg, Jos PhD
Page: 2178-2195


http://ift.tt/2sjVeQr

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.

Author: Chow, Sheryl L. PharmD, FAHA, Chair; Maisel, Alan S. MD, Vice Chair; Anand, Inder MD, DPhil, FAHA; Bozkurt, Biykem MD, PhD, FAHA; de Boer, Rudolf A. MD, PhD, FAHA; Felker, G. Michael MD, MHS, FAHA; Fonarow, Gregg C. MD, FAHA; Greenberg, Barry MD, FAHA; Januzzi, James L. Jr MD; Kiernan, Michael S. MD; Liu, Peter P. MD, FAHA; Wang, Thomas J. MD, FAHA; Yancy, Clyde W. MD, MSc, FAHA; Zile, Michael R. MD, FAHA; On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research
Page: e1054-e1091


http://ift.tt/2rm5Dhg

Highlights From the Circulation Family of Journals.

Author:
Page: 2196-2201


http://ift.tt/2skkhCW

3D Printers Provide a Window into the Heart.

Author: Kuehn, Bridget M.
Page: 2202-2203


http://ift.tt/2rm3out

Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease.

Author: Knowles, Joshua W. MD, PhD; Howard, William B. PhD; Karayan, Lala MPH; Baum, Seth J. MD; Wilemon, Katherine A. BS; Ballantyne, Christie M. MD; Myers, Kelly D. BS
Page: 2204-2206


http://ift.tt/2sk2CeE

The Revised Framingham Stroke Risk Profile in a Primary Prevention Population: The Rotterdam Study.

Author: Bos, Daniel MD, PhD; Ikram, M. Arfan MD, PhD; Leening, Maarten J. G. MD, PhD; Ikram, M. Kamran MD, PhD
Page: 2207-2209


http://ift.tt/2rmf7t9

Letter by Saritas Regarding Article, "Total Anomalous Pulmonary Venous Connection: The Current Management Strategies in a Pediatric Cohort of 768 Patients".

Author: Saritas, Bulent MD
Page: e1092


http://ift.tt/2rm9eft

Letter by Ghimire Regarding Article, "Total Anomalous Pulmonary Venous Connection: The Current Management Strategies in a Pediatric Cohort of 768 Patients".

Author: Ghimire, Laxmi V. MD
Page: e1093-e1094


http://ift.tt/2sknsKQ

Response by Chen to Letters Regarding Article, "Total Anomalous Pulmonary Venous Connection: The Current Management Strategies in a Pediatric Cohort of 768 Patients".

Author: Chen, Huiwen MD, PhD
Page: e1095-e1096


http://ift.tt/2rlXs4u

Αναζήτηση αυτού του ιστολογίου